Alkem Laboratories Ltd (BOM:539523)
₹ 5701.35 -20.05 (-0.35%) Market Cap: 682.30 Bil Enterprise Value: 653.78 Bil PE Ratio: 33.57 PB Ratio: 6.69 GF Score: 99/100

Q2 2021 Alkem Laboratories Ltd Earnings Call Transcript

Nov 06, 2020 / 12:00PM GMT
Release Date Price: ₹2752.1 (+0.07%)
Tushar Manudhane
Motilal Oswal Securities Limited, Research Division - Research Analyst

Welcome to Q2 FY '21 Earnings Call of Alkem Laboratories. From the management side, we have Mr. Sandeep Singh, Managing Director; Mr. Rajesh Dubey, Chief Financial Officer; Mr. Amit Ghare, President, International Business; Mr. Yogesh Kaushal, Senior Vice President, Chronic Division; and Mr. Gagan Borana from Investor Relations. Over to you, Gagan.

Gagan Borana
Alkem Laboratories Limited - General Manager of IR

Yes. And thank you for taking out time and joining us for Alkem Laboratories' Q2 and H1 FY '21 Earnings Call. Earlier during the day, we have released our financial results and the same are also posted on our website. To discuss the business performance and outlook going forward, we have on this call the senior management team of Alkem.

Before I proceed with this call, I would like to remind everybody that this call is being recorded and the call transcript will be made available on our website as well.

I would also like to add that this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot